During the past decade, Apollo Gleneagles Cancer Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Gleneagles Cancer Hospital" #1 collaborator was "Merck Ltd., India" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Apollo Gleneagles Cancer Hospital" are "Carcinoma, Squamous Cell" (1 trials), "Colorectal Neoplasms" (1 trials), "LA SCCHN" (1 trials) and "Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck" (1 trials). Many other conditions were trialed in "Apollo Gleneagles Cancer Hospital" in a lesser frequency.

Most popular intervention types in "Apollo Gleneagles Cancer Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (2 trials) and "Cetuximab + RT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Gleneagles Cancer Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Apollo Gleneagles Cancer Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Apollo Gleneagles Cancer Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Gleneagles Cancer Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".